Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5182_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
89 Мб
Скачать
366 Wild Edible Plants
types of inedible medicinal wood- decaying mushrooms, and its amount also increases signicantly in old fruiting bodies, as well as in the mycelium of edible mushrooms. It may be different in different parts of the mushroom fruiting bodies. For example, the stem of L. edodes have a higher ber content (45%) than the caps (36.6%), for other species studied, the difference was not so great. The chitin and the matrix components (α- and ß- D- glucans and mannans) are non- starch polysaccharides whose molecules can be classied as total dietary ber fraction (Cheung, 2013). Dietary ber in mushrooms primarily consists of water- soluble (less than 10% DW) and the insoluble fractions, with chitin and β- glucans being the most prevalent. These molecules are practically resistant to digestion and absorption in the human small intestine and have benecial effects such as attenuation of glucose and cholesterol in the blood.
There are many diverse substances in mushrooms that determine specic tastes and aromas that stimulate appetite and make mushrooms exceptionally attractive as a delicious product. For different mushroom species, the specic taste and smell are determined by the combination of many volatile components: alcohols, aldehydes, etc., as well as a combination of non- volatile substances such as soluble sugars, organic acids, free amino acids, and 5- nucleotides were determined (Hu et al., 2020; Kalač,
2013). Hu et al. (2020) detected in dried S. rugosoannulata fruiting bodies ve 5­nucleotides (5- AMP, 5- GMP, 5- UMP 5- CMP, and 5- IMP). The total content of 5′- nucleotides in pileus (18.33– 22.76 mg/ g) was higher than that of stipe (8.17– 11.91 mg/ g). Similar results were also observed by Wu et al. (2015) for H. marmoreus and Li et al. (2015) for P. eryngii.
Summing up all of the above, mushrooms are a nutritious food and an important source of bioactive constituents. It is extremely important to look at the selected prom­ising, widely cultivated mushroom species.
13.4 BIOACTIVE COMPOUNDS OF EDIBLE ANDMEDICINAL MUSHROOMS
13.4.1 Cyclocybe aegerita
Cyclocybe aegerita (V. Brig.) Vizzini (family Tubariaceae); common name: pioppino mushroom or velvet pioppini, poplar mushroom, chestnut mushroom, black poplar, swordbelt agrocybe, yanagi- matsutake (Figure 13.3A). C. aegerita is a popular edible mushroom widely distributed in Southern Europe, the Southeastern United States, and similar Asian climate zones that prefer warm to temperate climates. The black poplar mushroom is known for its delicious taste and has been cultivated since ancient Rome. When cooked, pioppino has a nutty avor and crunchy texture. C. aegerita is rich in proteins, carbohydrates, and polyunsaturated fatty acids and has a low- fat content. In ad dition, pioppino contains several biologically active substances such as polysaccharides, phenols, indole derivatives, and tocopherols, unique ceramides with proven antitumor potential. Pioppino could be a source of enzymes (peroxidases, laccases, proteases,
Edible and Medicinal Mushrooms as an Eco-Friendly Source of Food 367
FIGURE 13.3 Fruiting bodies: A Cyclocybe aegerita; B Hericium erinaceus; C Hypsizygus marmoreus; D Lentinula edodes; E Pleurotus eryngii; F Stropharia rugosoannulata. Photos
of the authors.
and lipoxygenases), which are promising biocatalysts in biotechnological applications (Cateni et al., 2022; Landi et al., 2017b, 2022).
13.4.1.1 Components of Cyclocybe aegerita with proven pharmacological activities
Polysaccharides are the most abundant biologically active substances in the fruiting bodies and mycelium of C. aegerita and have become an important component in the research and development of natural medicines and health products (Jing et al., 2018). Mushroom polysaccharides are considered effective antioxidants with a complex struc­ture. Natural polysaccharides are conjugated with other bioactive components such as proteins, phenolic compounds, amino acids, and lipids. Several recent studies have found that polysaccharides from C. aegerita have great potential for antioxidant and antiaging functions, as well as antitumor, antiangiogenic, and thrombosis treatment properties (Jing et al., 2018; Liu et al., 2020a, 2020b; Peng et al., 2022; Wu et al., 2022).
The polysaccharide from C. aegirita showed potent antiaging activity, manifested by increasing cell viability and β- Gal viability, preventing cell cycle arrest in the G1 phase and reducing mitochondrial membrane potential (Liu et al., 2020a, 2020b). Wu et al. (2022) reported that C. aegerita polysaccharide in combination with Lactobacillus rhamnosus GG acted as a prebiotic and helped mitigate the damage caused by aging by regulating oxidative stress and gut microbiota. Also, Liu et al. (2022) studied the impact of combining C. aegerita polysaccharides with Bidobacterium lactis Bb- 12 on antioxidant activity, antiaging properties, and modulation of gut microbiota. The results demonstrated that the polysaccharides and Bidobacterium lactis Bb- 12 com­plex signicantly increased the average lifespan of male and female mice under natural aging. Additionally, the complex enhanced their climbing ability and increased anti­oxidant enzyme activity, protecting them from oxidative damage induced by H2O2. In
368 Wild Edible Plants
D- galactose- induced aging mice, the addition of complex resulted in a signicant increase in antioxidant enzyme activity, regulation of aging- related biomarker levels, changed gut microbiota diversity, restoration of microbial structure, and increased abun­dance of benecial bacteria, particularly Lactobacilli, in the intestines.
Additionally, Ji et al. (2013) investigated the antitumor mechanism of polysac­charide from C. aegerita by evaluating the expression of tumor necrosis factor- α (TNF- α) and interferon- γ (IFN- γ) in rat esophageal carcinoma. The rats were given anticancer treatment daily for 4 weeks. It was found that C. aegerita polysaccharide in combin­ation with chemotherapy can regulate immune function in rat esophageal carcinoma, potentially by modulating cytokine activity, in particular, reducing TNF- α levels and increasing IFN- γ levels (Ji et al., 2013).
Ferments. Pecyna et al. (2009) presented genetic information about this new group of mushroom peroxidases known as aromatic peroxygenases (APOs). The C. aegerita peroxygenase gene (Apo 1) has been identied at the messenger RNA and genomic DNA level. The gene sequence was conrmed using peptide sequences. Aromatic peroxygenases are multifunctional peroxide- consuming enzymes involved in the biodesulfurization, dehalogenation, denitrication, and hydroxylation of various aro­matic compounds. The most studied biocatalyst of this type is C. aegerita. Aromatic peroxygenases from C. aegerita catalyze reactions such as the peroxidation of naphtha­lene, toluene, dibenzothiophene, or pyridine, which effectively act on cytochrome P450 monooxygenases. APO is an attractive biocatalyst capable of carrying out a wide range of complex reactions and may be promising for use in organic synthesis. According to the literature data, C. aegerita APO is capable of sulfoxidation and hydroxylation of dibenzothiophene, hydroxylation of the ring and side chain of toluene, N- oxidation of pyridine, as well as selective epoxidation of naphthalene. APO enzymes are secreted heme- thiolate proteins (Pecyna et al., 2009). Also, Kluge et al. (2009) reported the mechanism of peroxygenase- catalyzed oxygen transfer by the example of naphtha­lene that is regioselectively hydroxylated into 1- naphthol. Due to their extracellular nature, the high degree of glycosylation (20– 40%), and hence high stability, APA­related enzymes could become new model biocatalysts for oxygen transfer reactions (Kluge et al., 2009).
Li et al. (2021) isolated a novel brinolytic enzyme (ACase) from the fruiting bodies of C. aegerita. It has been established that the ACase enzyme can destroy all three chains (α, β, and γ) of brinogen. Moreover, it acted not only as a plasmin- like brinolytic enzyme but also as a plasminogen activator. The authors reported that the enzyme could slightly hydrolyze human thrombin, inhibit thrombin activity, and act as an anticoagulant to prevent thrombosis. Based on their results, the authors suggested that ACase may act as a therapeutic agent for the treatment of thrombosis or as a func­tional food product, but further research is needed (Li et al., 2021).
Phenolics compounds are considered important metabolites with clinically useful activities. The antioxidant activity and free radical scavenging ability of C. aegerita correlated with total phenolic content (Lin et al., 2017; Lo & Cheung, 2005). The fruiting bodies of C. aegerita contained protocatechuic acid, chlorogenic acid, ferulic acid, and sinapic acid (Lin et al., 2017). The aqueous extract of C. aegerita fruiting bodies had a total phenolic content (TPC) of 13.67±0.21 M gallic acid
Edible and Medicinal Mushrooms as an Eco-Friendly Source of Food 369
equivalent (GAE)/ mg extract. In addition, the effects of phenolic- rich aqueous extract on antiogenesis- related expression of vascular endothelial growth factor (VEGF) secre­tion and angiogenesis- related signaling in tumor cells, were investigated. The model chosen for the experiment was the use of Caco- 2 cells (colon epithelial tumor cells) and HUVEC (endothelial cells). The authors report that a decrease in intracellular reactive oxygen species (ROS) levels and secretion of VEGF expression was observed when treated with C. aegerita extract, and in Caco- 2 cells (colon epithelial tumor cells) treated with C. aegerita. The aqueous extract inhibited the VEGF induced proliferation in human umbilical vein endothelial cells (HUVECs). Down- regulation of intracel­lular ROS level and VEGF secretion were also observed in Caco- 2 cells treated with aqueous extract of C. aegerita. Inhibition of other angiogenic cascades in HUVECs included a decrease in the migration of endothelial cells (ECs) by 46.14±8.53%. Authors reported that the presence of antiangiogenic properties of extracts C. aegerita in vitro and phenolics might contribute to the effect.
Thus, it has been experimentally proven that C. aegerita contains many nutrients and bioactive components including polysaccharides, which are the main active compounds having great potential for antioxidant and antiaging functions. When combined with Lactobacillus rhamnosus GG and Bidobacterium lactis Bb- 12, they may act as a pre­biotic and help mitigate the damage caused by aging by regulating oxidative stress and gut microbiota. In addition, polysaccharides have multiple physiological functions, such as antioxidant, antitumor, antiangiogenic, and thrombosis treatment properties.
13.4.2 Hericium erinaceus
Hericium erinaceus (Bull.) Pers. (family Hericiaceae), common name Lion’s mane, pom pom, bearded tooth, known also as bear’s head, hog’s head fungus, old man’s beard, white beard, monkey’s mushroom, monkey’s head or “Houtou” in Chinese, and moun­tain monk mushroom or “Yamabushitake” in Japanese (Figure 13.3B). H. erinaceus is a popular culinary and medicinal mushroom cultivated in many European coun­tries, North America, and Asia. In natural conditions, it grows in South East Asia (China and Japan), Europe, and North America, and is also found in Ukraine. In folk medicine, it is used for immune stimulation and antiseptic for treating chronic gas­tritis, cancer of the oesophagus and stomach, leukemia, treating the nervous system, and rst of all, neurodegenerative disorders. H. erinaceus is a good source of proteins and carbohydrates, low in fat (Table 13.1). Also, the mushroom composition includes dietary bers, essential amino acids, minerals, vitamins, and ergosterol (provitamin D2) making it a high- quality, low- calorie food (Cohen et al., 2014; Das et al., 2021; Mau et al., 2001; Rodrigues et al., 2015; Thongbai et al., 2015).
Current information on the medicinal properties of H. erinaceus indicates a wide biological spectrum of its action. The H. erinaceus composition includes various metabolites such as β- glucans polysaccharides and secondary metabolites such as terpenoids (hericenones, erinacine), sterols, and isoindolinones. Immunomodulatory, anticancer, anti- inammatory, gastroprotective, cytoprotective, antioxidant, antibac­terial, hypoglycemic, and hepatoprotective effects of H. erinaceum extracts are reported, as well as its neuroprotective, neurotrophic, and neuro- regenerative properties.
370 Wild Edible Plants
13.4.2.1 Components of Hericium erinaceus with proven pharmacological activities
The bioactive metabolites found in H. erinaceus can be classied into two groups: high molecular weight compounds, including polysaccharides, and low molecular weight compounds, such as terpenoids and polyketides.
Polysaccharides. The H. erinaceus fruiting bodies and mycelial mass contain glucans and glucan- protein complexes. More than 35 polysaccharides with multiple activities have been extracted from H. erinaceus mycelia (Spelman et al., 2017). Anticancer and immunostimulating effects of polysaccharides from H. erinaceus are primarily associated with the activation of many immune cells (T- cells, macrophages, and cytokines), as well as increasing the ability of the immune system cells to nd and destroy migrating cancer cells in the human body (Jiang et al., 2014; Zhang et al., 2022). Unlike much­existing chemotherapy of anticancer drugs, polysaccharides isolated from H. erinaceus do not have a toxic effect. Such polysaccharides can activate c- Jun N- terminal kinases (JNK), which participate in apoptosis, and enhance the intracellular apoptotic signal level (Badalyan & Rapior, 2020). Numerous tests were conducted in vitro and in vivo showed signicant therapeutic potential of metabolites of the H. erinaceus mushroom with promising results against a variety of cancers, including those in the breast, blood, colon, liver, lungs, sarcoma, and stomach (Kim et al., 2014; Ma et al., 2012; Thongbai et al., 2015). A study of the immunomodulatory potential indicated that the polysac­charide fraction of ethanol extracts of H. erinaceus and its derivatives can promote the maturation of dendritic cells, their production of cytokines, and the proliferation of T- cells, as well as activation of macrophages and increase production of tumor necrosis factor (TNFα) (Ren et al., 2017).
Terpenoids. Various diterpenes and sesterpenes are present in H. erinaceus. The most interesting are two classes of terpenoid compounds: hericinones and erinacines obtained from fruiting bodies and cultivated mycelium, respectively. Hericinones, a class of aro­matic compounds, were isolated from the H. erinaceus fruiting body by Kawagishi et al. (1990). They pointed out the perspective of using hericinones as natural remedies against Alzheimer’s disease, assuming the possibility of their passing through the blood- brain barrier and inducing the production of neurotrophic growth factor (NGF) in the brain. Hericenones A and B showed signicant cytotoxicity against HeLa cells (Kawagishi et al., 1990). In addition, hericenon B effectively inhibits the aggregation of platelets, which prevents thrombosis, heart attacks, and strokes. However, hericenones C, D, E, and H showed a stimulating effect activity in the synthesis of NGF in vitro. On the other hand, hericenones F and G did not stimulate NGF synthesis under the same conditions, but 3- hydroxyhericenone F protected against neuronal death (Kawagishi et al., 1991). Hericenones I, J, and L showed cytotoxic activity against EC109 tumor cells (Ma et al.,
2012). It is still controversial whether all hericenones are active components in stimu-
lating NGF biosynthesis. Some researchers have shown that hericinones C, D, and E did not increase NGF biosynthesis in the 1321N1 cell line (Mori et al., 2008). Instead, Phan et al. (2018) investigated the stimulation of NGF synthesis by hericenon E cells
Edible and Medicinal Mushrooms as an Eco-Friendly Source of Food 371
in rat pheochromocytoma (PC12) using several pharmacological inhibitors. In addition to the above- mentioned, hericenones isolated from fruiting bodies, another class of ter­penoid compounds, a group of cyathane- type diterpenoids, named erinacines (A– I), was obtained from cultured mycelium (Jing et al., 2022; Roda et al., 2021; Spelman et al., 2017). Erinacines are low- molecular substances that stimulate synthesis of NGF through interaction with mitogen- activated protein kinase of neurons and can overcome hematoencephalic barrier. Erinacine derivatives are potential drugs for degenerative disorders of neurons and peripheral regeneration nerves. Thus, the cyanine- diterpenoid erinacine A, obtained from the H. erinaceus mycelium, demonstrated inhibitory activity against a wide range of cancer cells associated with the gastrointestinal tract and has been proven to have an effective protective effect against Parkinson’s disease (Venturello et al., 2021). Ratto et al. (2019) reported the positive effect of an H. erinaceus supplement (He1) with a known amount of Erinacine A, Hericenone C, Hericenone D, and L- ergothioneine, on locomotor frailty and cerebellum of aged mice by inves­tigating specic protein markers representative of cell proliferation activity and new­born neurons occurrence. Effect of erinacine A- enriched H. erinaceus supplementation (HE) on cognitive function and serum levels of the brain- derived neurotrophic factor (BDNF), neuropeptide Y (NPY), fecal levels of chitinase, and gut microbiota composi­tion has been investigated by Bizjak et al. (2024) in clinical trials. They observed a signicant improvement in cognitive ability and an increase in gut microbiota diversity, which was positively correlated to NPY levels. Supplementing the diet with HE was acknowledged as a safe and well- tolerated intervention with a neurocognitive benet (Bizjak et al., 2024).
Some studies were conducted with H. erinaceus extracts regarding the mechanisms involved in the process of brain neuroprotection (Kushairi et al., 2019; Mori et al., 2008, 2009; Phan et al., 2018). Effects of erinacine A, which can prevent ischemic injury neurons and act as an anti- inammatory agent, have been reported (Thongbai et al., 2015).
Erinacerins. Wang et al. (2015) isolated ten new isoindoline- 1- ones, named erinacerins C−L from a solid H. erinaceus culture. This is another group of secondary metabolites produced by H. erinaceus. Some of the compounds inhibited the growth of cancer cells.
Sterols. In the fruiting body of H. erinaceus, ten erinarols A– J, ve ergostane- type sterol fatty acid esters, and ten ergostane- type sterols have been identied. Sterols, such as ergosterol, confer antioxidative properties. H. erinaceus has been identied as the most potent inhibitor of both low- density lipoprotein (LDL) oxidation and HMG Co- A reductase activity in vitro, indicating potential therapeutic applications for preventing oxidative stress- related vascular diseases (Spelman et al., 2017). Dai et al. (2015) evaluated the biomass and ergosterol content of H. erinaceus myce­lium using plant- derived compounds supplementation into liquid culture and got the highest ergosterol content of 2.33 mg/ g after 6 days of cultivation with 100 mol/ L salicylic acid (Dai et al., 2015; Friedman, 2015). Some of these compounds exhibit anti- inammatory and antiproliferative properties in cell assays (Cui et al., 2014; Friedman, 2015).
372 Wild Edible Plants
Glycoprotein and glycolipids. Interestingly, H. erinaceus is not just a source of low molecular weight biologically active compounds, but also some proteins that have a considerable tumor suppressive potential. Thus, the HEP3 protein isolated from H. erinaceus exhibited immunomodulatory activity in lipopolysaccharide- activated macrophages by decreasing the overproduction of tumor necrosis factor- α, interleukin (IL)- 1β, and IL- 6, and downregulating the expression of inducible nitric oxide synthase and nuclear factor- κB p65. The further immunomodulatory effect was caused by the stimulation of intestinal microbiota with protein, which included activation of prolife­ration and differentiation of T- cells and stimulation of antigen- presenting cells of the intestine (Diling et al., 2017). Another example of a biologically active protein isolated from H. erinaceus is a glycoprotein HEG- 5, which was able to induce apoptosis in the gastric cancer cell line SGC- 7901, stimulating expression of some proapoptotic factors (Zan et al., 2015). Cui et al. (2014) reported on the isolation of a novel glycoprotein (HEG- 5) from cultures of H. erinaceus mycelia. The compound has a molecular weight of 14.4 kDa and was shown to have hemagglutinating activity. Analysis using FT- IR and NMR showed that HEG- 5 contains the protein and carbohydrate parts with (1→4)- linked β- galactose and β- glucose residues, and circular dichroism showed that the HEG­5 is a predominantly β- sheet glycoprotein. The glycoprotein inhibited the growth of human gastric carcinoma cells (Cui et al., 2014; Friedman, 2015).
Cerebrosides are natural organic compounds from the group glycolipids, another class of compounds found in mushrooms. It is shown that cerebroside E, isolated from H. erinaceus fruiting bodies, exhibited a signicant inhibitory effect on angiogenesis in HUVECs. This compound has also been shown to have antitoxic properties, and attenuated cisplatin- induced nephrotoxicity in LLC- PK1 cells, which is sufcient to propose its use in a cancer chemotherapy protocol (Lee et al., 2015).
Neuroprotective and neurotrophic effects. It is reported above that the fruiting bodies and mycelia of H. erinaceus produce several classes of biologically active molecules, including polysaccharides, proteins, lectins, phenols, and terpenoids. Erinacine A has been shown to cause potent restore nerves, strengthens their properties and effectively inhibits death of neuronal cells. It can enhance the synthesis of NGF by increasing the secretion of norepinephrine and catecholamines. Cyatane- xyloside of erinacin P and its biochemical transformations in erinacine A as well as erinacine B induced the NGF synthesis (Thongbai et al., 2015). It has been found that erinacine A was able to prevent ischemic injury to neurons and act as an anti- inammatory agent. The use of hericenone C and erinacine A recommended for improving memory functions and improvement teaching. These compounds can signicantly affect synthesis of NGF in vitro and/ or in vivo (Jiang et al., 2014; Khan et al., 2013; Soares et al., 2013; Thongbai et al., 2015).
Amycenone (amyloban), which is an activator of brain function and can exert a protective effect on brain cells in culture protecting them from damage by amyloid peptides, was isolated from H. erinaceus extracts (Inanaga, 2012). As shown in further studies, hericenones and amyloban, which are effective against damage to the human brain in Alzheimer’s and Parkinson’s diseases. Organic extracts from fruiting bodies of H. erinaceus possess a neurotropic effect that enhances the myelination process in mature myelin bers (Moldavan et al., 2007). Bioactive compounds extracted from the mycelia and fruiting bodies of H. erinaceus may be used as a potential alternative
Edible and Medicinal Mushrooms as an Eco-Friendly Source of Food 373
medicine for the treatment of depression (Chong et al., 2020). Laboratory studies proved the absence of any negative consequences of using H. erinaceus. The clinical studies with amiloban indicate its promising results against dementia and Alzheimer’s disease, primarily due to the absence of any side effects (Thongbai et al., 2015). In addi ­tion, amycenone reduces excess body weight and attenuates hyperlipidaemia in mice by inhibiting lipogenesis and promoting lipolysis through lipid metabolism pathway stimulation and fatty acid β- oxidation acceleration (Kudo et al., 2022).
Thus, H. erinaceus has numerous biological activities. Hericenones and erinacines stimulate NGF, which suggests that H. erinaceus has a certain inu­ence on the functioning of the brain and the autonomic nervous system, and taking H. erinaceus gives the ability to reduce depression and anxiety (Limanaqi et al., 2020). Polysaccharides from H. erinaceus with different molecular weights not only play a role in the immunomodulation of dendritic cells but also demonstrate neuroprotective effects for neurons.
Antimicrobial effect and antioxidant activity. Antimicrobial effect of Hericium species due to ability to produce antibacterial metabolites with a wide and narrow spectrum of action was shown in numerous studies (Khan et al., 2013; Lomberg et al., 2023; Narmuratova et al., 2022; Song et al., 2020; Thongbai et al., 2015). This can have poten ­tial health benets and could be recommended for further analysis, isolation and identi­cation of antibacterial compounds potentially promising in pharmacology.
Ryu et al. (2009) showed the presence of ergothioneine and polyphenols in bio­mass of H. erinaceus and H. coralloides. Meanwhile, ergothioneine, which humans are unable to synthesize, a unique sulphur- containing amino acid, is an antioxidant, cytoprotective, and anti- inammatory element with therapeutic potential approved by World Food Agencies (Bell et al., 2022; Roda et al., 2022).
Thus, H. erinaceus is among the highly praised edible mushrooms, as producers of neuroprotective biomolecules. Its traditional use for chronic ailments, coupled with the ndings of current studies, indicates that H. erinaceus is safe and holds signi­cant potential as a neuroprotective and neurotrophic therapeutic agent for neurological conditions. Its rich micronutrient composition suggests that utilizing the entire fungus could be the most benecial approach clinically. Thus, preparations from H. erinaceus are already available today to prevent and improve conditions with Alzheimer’s disease, Parkinson’s disease, and dementia, as well as in sports medicine. Despite all the va riety of neurotrophic effects of macromycetes on the human body, functional changes in the nervous system, which are the basis of the described effects, have been studied not enough, the vast majority of the results described in the review, carried out on cell lines and experimental animals (in vitro and in vivo), and require further observations.
13.4.3 Hypsizygus marmoreus
Hypsizygus marmoreus (Peck) H.E. Bigelow (family Lyophyllaceae), common name Beech mushroom or buna- shimeji (bunashimeji), brown beech or brown clamshell mushroom, mountain echo mushroom or yamabiko hon- shimeji (Figure 13.3C). H. marmoreus is native to forests of Asia, North America, and Europe, and is now
374 Wild Edible Plants
widely cultivated. The main producers of its fruiting bodies are the countries of East Asia, mainly Japan. H. marmoreus is a highly nutritious edible mushroom, valuable for its delightful taste and signicant medicinal properties. Brown beech mushrooms and their white variety are popular dietary mushrooms in East Asian regions, including China, Japan, and Taiwan. Both fruiting bodies and mycelia are good sources of polysaccharides, protein, essential amino acids, soluble sugar, lectins, vitamins, enzymes, and avor nucleotides (Lee et al., 2009; Liu et al., 2016; Liu et al., 2018; Wu et al., 2014). Because of the presence of these compounds, this species shows a variety of properties, including anticancer, antioxidant, anti- inammatory, antihypertensive, and antiallergic effects (Liu et al., 2018; Xu et al., 2020).
13.4.3.1 Components of Hypsizygus marmoreus with proven pharmacological activities
Polysaccharides extracted from mushroom mycelia have been shown to possess a wide range of benecial biological properties. Published data demonstrated that polysaccharides play crucial roles in preventing and treating oxidative damage, suggesting their poten­tial development as antioxidants (Badalyan et al., 2019; Liu et al., 2018). Many experi ­mental works on H. marmoreus polysaccharides demonstrated their anticancer and antioxidant properties (Chang, 2004; Motoi, 2003; Ye et al., 2023). On a number of test systems, extracts from the fruiting bodies and mycelium of the beech mushroom along with inhibiting the development of carcinoma metastases, also showed signicant antioxidant activity. Based on these studies, extracts were made from H. marmoreus and F. velutipes, and a preparation called “EEM” (extracts of edible mushrooms) was supplied. Clinical studies of EEM were performed and the effects of EEM alone and in combination therapy of EEM and cancer chemotherapy agents for advanced cancer patients were studied and a positive effect of EEM was found (Ikekawa, 2005). Liu et al. (2018) reported that H. marmoreus mycelia polysaccharides (MPS) have shown anti­ammation effects against lung damage induced by lipopolysaccharides in mice.
In recent years, increasing attention has been paid to selenium- enriched polysaccharides showing higher antioxidant effects than regular polysaccharides, which allows garnering them as a safe and effective selenium resource. Thus, H. marmoreus cultivated in a liquid medium with Na2SeO3 accumulated in mycelia polysaccharides containing 70.15 g/ g selenium (MSPS) (Liu et al., 2016). The antioxidant activities in vitro demonstrated that MSPS had potential effects on scavenging reactive oxygen species and enhancing the reducing power. The treatment of MSPS in vivo demonstrated that the MSPS could reduce the levels of malondialdehyde, lipid peroxide, glutamic oxaloacetic transaminase, and glutamic- pyruvic transaminase activities and improve the levels of glutathione peroxidase, superoxide dismutase, total cholesterol, and trigly­ceride in serum/ liver homogenate against CCl4- induced injures (Liu et al., 2016).
Indole compounds presented in H. marmoreus are an important group of compounds with procognitive, antidepressant, antioxidant, and neuroprotective properties (Kała et al., 2022). Six indole compounds such as L- tryptophan, 5- hydroxy- L- tryptophan, serotonin, tryptamine, 5- methyltryptamine, and melatonin were identied. An essen­tial amino acid L- tryptophan, which is a precursor of neurotransmitters in the body, was found in all samples, with the highest content observed in brown H. marmoreus
Edible and Medicinal Mushrooms as an Eco-Friendly Source of Food 375
(8.97– 72.1 mg/ 100 g DW). In mycelial cultures the L- tryptophan content ranged from
17.3 to 25.6 mg/ 100 g DW. The higher antiradical properties of mushrooms could be related to the content of indole compounds (Angelini et al., 2023). Authors suggested that the enrichment of the growth medium with grape pomace could implement the medicinal properties of H. marmoreus, whose content in terpenoids, carbapenems, and indoles was signicantly increased compared with the mushrooms cultivated in the standard medium, as shown by ABTS assay, could be related to the presence of indole compounds. Indeed, the extract with the highest content of indole compounds had the highest antioxidant effect.
Sterols, especially ergosterol, are converted into vitamin D2 in the presence of ultra- violet rays, which plays an important role in the prevention of cancer and regulates other immunomodulatory functions. Ergosterol is also responsible for the absorption of Ca and P, which contribute to the proper functioning of the skeletal system. Ergosterol content in white and brown H. marmoreus fruiting bodies consisted of 74.8 and 116 mg/ 100 g DW, respectively (Kała et al., 2022). Among the analyzed H. marmoreus samples, the highest ergosterol contents were observed in the brown and white strains mycelium grown on the medium enriched with adding Zn and Mg (166 and 142 mg/ 100 g DW, respectively). So, the addition of magnesium and zinc salts to the culture medium increased both the ergosterol and ergosterol peroxide contents in the mycelium compared with the non- enriched cultures.
Phenolic compounds. Xu et al. (2020) compared phenolics, antioxidant activities, and antiproliferative properties in brown and white H. marmoreus fruiting bodies. The results showed that the contents of catechin, gallic acid, and protocatechuic acid of brown fruiting bodies were higher than those of white. Moreover, brown had greater cellular antioxidant activity, peroxyl radical scavenging capacity and oxygen radical absorb­ance capacity values than the white one, which demonstrated that brown H. marmoreus presented a stronger antioxidant capacity. Both brown and white H. marmoreus showed remarkable antiproliferative activities against HepG2 cells and brown H. marmoreus was proven to be the more effective.
Ukaegbu et al. (2020) reported that tested aqueous and methanol extracts of H. marmoreus (brown and white var.) and F. velutipes caps against two breast cancer cell lines showed possess higher antioxidant activities against DPPH: aqueous caps extracts of F. velutipes and white H. marmoreus (IC50= 0.202 and 0.573 mg/ mL, respect­ively), and H2O2 (IC50= 0.622 and 0.745 mg/ mL, respectively) compared to the methanol extracts. Aqueous extracts of the mushrooms also showed better ferric reducing anti­oxidant power values against ferric ions compared to the methanol extracts. Finally, the mushroom extracts showed good antiproliferative activities against human breast cancer cell lines. The highest phenylalanine and cinnamic acid contents were determined in the brown fruiting bodies of commercial origin, 422 and 8.88 mg/ 100 g DW, respec­tively (Kała et al., 2022). In addition to their well- known antioxidant activity, phenolic compounds found in mushrooms can exhibit signicant antimicrobial effects against a wide range of organisms (Angelini et al., 2023). The antimicrobial activities of extracts from H. marmoreus against Gram- positive and Gram- negative bacteria, yeasts, dermatophytes, as well as phytopathogenic fungi, have been reported (Angelini et al.,
2023).